Delivery Order SPE2DR25D1053-SPE2DR26FV831
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 100 tablets of Concerta ER 27 mg, valued at $1,815.45. The award, issued on December 1, 2025, with a completion date of December 2, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under the company's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER Tablets 36mg, with a ceiling value of $1,849.39. This firm fixed-price, non-set-aside contract was awarded on June 6, 2025, with an ultimate completion date of June 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order serves as a child contract under the company's existing...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,948.54 on July 14, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Concerta ER (extended-release) 27 mg tablets. This competitively awarded, firm fixed-price delivery order has a ceiling value of approximately $24.9K and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a delivery order, this contract is...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency on January 15, 2026, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $17,447.90 and an ultimate completion date of January 16, 2026. The award is a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.42 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100-unit quantity) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price contract, which involves no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $6,600.47 for Concerta ER 18 mg tablets (100-count packages). This competitive, firm fixed-price contract was awarded on June 18, 2025, with an ultimate completion date of June 20, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Concerta ER 54 mg tablets (100 count) valued at $1,466.08, with an ultimate completion date of December 10, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Concerta ER 18 mg tablets (100-count units) valued at $9,775.73. The contract utilizes a firm fixed-price structure with an ultimate completion date of January 15, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle extending through...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV831Delivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 28, 2026, valued at $4,293.05 for the supply of Concerta ER 36 mg tablets (100-count units). This firm fixed-price, non-set-aside contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in supplying prescription medications, vaccines, medical devices, and healthcare commodities to military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains on a competitive basis. This particular delivery order for Concerta ER—a controlled-release methylphenidate medication used for attention deficit hyperactivity disorder treatment—represents routine pharmaceutical procurement under the established prime vendor contract framework supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 1/27/26 |